Cyclacel Pharmaceuticals (CYCC) Financials

$5.13

$-1.64 (-24.22%)

As on 10-Oct-2025 09:30EDT

Market cap

$14 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0

P/B Ratio

3.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	-0.03	0.04	0.42	0.37	--	0.01
Cost of Revenue	0.01	0.01	0.03	0.03	0.04	0.02
Gross Profit	-0.03	0.04	0.42	-0.03	-0.04	-0.02
Operating Expenses	10.37	12.05	25.87	27.66	22.39	10.64
Operating Profit (EBIT)	-10.36	-12.00	-25.45	-27.66	-22.94	-10.64
Other Income	--	--	--	--	--	-2.82
Profit before Tax	-5.42	-11.99	-25.55	-25.92	-22.19	-9.68
Provision for Tax	0.99	-0.78	-3.00	-4.72	-3.85	-1.24
Profit after Tax (Net Income)	-6.41	-11.21	-22.56	-21.20	-18.89	-8.45
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-21.40	-19.09	-8.65

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	0.00	-2.17	0.61	20.43	37.69	33.26
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.00	--	0.04	0.11	0.03	1.06
Current Liabilities	0.00	6.27	8.16	7.51	5.41	2.49
Total Liabilities	0.01	4.09	8.81	28.05	43.14	36.80

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.00	0.42	1.36	3.64	1.65	1.33
Current Assets	0.00	3.67	7.44	24.41	40.94	35.47
Total Assets	-3.61	4.09	8.81	28.05	43.14	36.80
Total Debt*	0.01	--	0.04	0.11	0.03	1.06
Net Current Assets	3.62	-2.59	-0.72	17.02	35.65	32.98

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-7.99	-16.11	-20.83	-18.54	-7.93
Cash Flow from Investing Activities	--	--	-0.01	-0.01	-0.03	-0.10
Cash from Financing Activities	--	7.82	0.85	3.00	21.74	29.50
Net Cash Inflow / Outflow	--	--	--	--	--	21.47

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-90.74	-303.85	-26.41	-25.36	-28.79	-12.67
Cash EPS ($)	--	-303.69	-26.37	-25.32	-28.73	-12.64
Adjusted Book Value ($)	--	--	0.71	24.44	57.46	49.89
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-216.53	-18.87	-24.92	-28.26	-11.90
Free Cash Flow per Share ($)	--	-216.53	-18.87	-24.92	-28.30	-12.05

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	1,465.62	-212.95	-72.77	-52.44	-35.78
ROE (%)	--	1,431.01	-214.40	-72.94	-53.24	-37.57
ROA (%)	-108.96	-173.84	-122.40	-59.56	-47.25	-32.41
EBIT Margin (%)	41,434.00	-27,916.28	-6,060.24	-7,414.48	--	-180,976.69
Net Margin (%)	25,632.00	-26,074.42	-5,370.24	-5,683.11	--	300.09
Cash Profit Margin (%)	8.54	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-131.25	-0.90	0.13	--	-1.00	--
EBIT Growth (%)	48.72	52.84	7.97	-21.65	-113.75	-9.85
Net Profit Growth (%)	63.40	50.29	-6.40	-12.24	-123.65	-7.88
EPS Growth (%)	-413.42	-10.50	-0.04	0.12	-1.27	-0.39
Book Value Growth (%)	-99.61	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	0.00	0.00	-0.10	-0.03	-0.14	-0.62
Price / Book Value	3.68	-0.01	3.76	0.03	0.07	0.16
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.02	0.26	0.04	0.64	1.50	2.56
Close Price ($)	4.95	90.24	640.80	2,401.20	14,004.00	28,116.00
High Price ($)	597.60	960.00	13,986.00	16,290.00	41,112.00	70,552.80
Low Price ($)	3.75	74.42	528.00	1,918.08	11,340.00	11,232.00
Market Cap ($ Cr)	14.25	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	--	0.06	0.01	0.00	0.03
Short term debt to equity ratio	--	--	--	--	--	0.00
Current Ratio	5.77	0.59	0.91	3.25	7.56	14.27
Quick Ratio	5.77	--	1.60	4.00	7.46	13.99
Interest Coverage	-677,749.00	--	-12.69	-13.79	-78.12	-10.67

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	-200.00	551.16	698.33	1,250.40	--	22,341.33
Asset Turnover	0.00	0.01	0.02	0.01	--	0.00
Receivable days	--	13,463.28	3,303.34	4,108.33	--	82,005.68
Inventory Days	--	-343,335.00	-64,375.31	-28,894.70	5,355.58	12,665.04
Payable days	--	247,822.13	34,835.72	26,697.49	11,174.10	12,820.28
Cash Conversion Cycle	--	-577,693.84	-95,907.69	-51,483.86	--	81,850.45

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.